Home > NRC Library > ADAMS Public Documents

License 20-28108-01 for Alcor Therapeutics,authorizing use of 5 mCi H-3,500 mCi C-14,1 mCi S-35,1 mCi Cr-51 & 500 mCi I-125 for R&D.

Accession Number: ML20245H392

Date Released: Thursday, October 24, 2024

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20245H395 - Forwards License 20-28108-01. (2 page(s), 2/18/1988)
• ML20245H398 - Responds to 871118 request for further clarification on questions re application for license.Change requested in licensee original application to reflect listed possession limits. (5 page(s), 1/12/1988)
• ML20245H401 - Requests addl info listed in order to continue review of 870921 application for license. (2 page(s), 11/19/1987)
• ML20245H406 - Forwards application for license. (1 page(s), 10/1/1987)
• ML20245H417 - Application for license,authorizing use of 25 mCi H-3 & 10 mCi each of C-14,S-35,Cr-51 & I-125 for R&D.Fee paid. (22 page(s), 9/21/1987)